MoneyWorks4Me

Godavari Drugs - Quaterly Results

13 Aug 2025 Evaluate
A decrease in the sales to Rs. 238.11 millions was observed for the quarter ended June 2025. The sales stood at Rs. 322.08 millions during the similar quarter previous year.Net profit of the cmpany stood at Rs. 10.41 millions for the quarter ended June 2025 a decline of -36.21% from Rs. 16.32 millions  in the same quarter last year.Operating Profit reported a sharp decline to 29.12 millions from 39.98 millions in the corresponding previous quarter.


(Rs. in Million)


  Quarter ended Year to Date Year ended
  202506 202406 % Var 202506 202406 % Var 202503 202403 % Var
Sales 238.11 322.08 -26.07 238.11 322.08 -26.07 1133.50 1567.12 -27.67
Other Income 0.12 7.65 -98.43 0.12 7.65 -98.43 9.77 6.18 58.09
PBIDT 29.12 39.98 -27.16 29.12 39.98 -27.16 128.04 139.22 -8.03
Interest 10.05 14.35 -29.97 10.05 14.35 -29.97 47.32 49.15 -3.72
PBDT 19.07 25.63 -25.60 19.07 25.63 -25.60 80.72 89.17 -9.48
Depreciation 6.04 5.50 9.82 6.04 5.50 9.82 24.48 19.95 22.71
PBT 13.03 20.13 -35.27 13.03 20.13 -35.27 56.24 69.22 -18.75
TAX 2.62 3.81 -31.23 2.62 3.81 -31.23 12.45 13.73 -9.32
Deferred Tax 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
PAT 10.41 16.32 -36.21 10.41 16.32 -36.21 43.79 55.49 -21.08
Equity 75.30 75.30 0.00 75.30 75.30 0.00 75.30 75.30 0.00
PBIDTM(%) 12.23 12.41 -1.48 12.23 12.41 -1.48 11.30 8.88 27.15
Peers
Company Name CMP
Sun Pharma. Inds. 1844.00
Dr. Reddys Labs. 1212.00
Cipla 1381.00
Lupin 2120.10
Zydus Lifesciences 1161.00
View more..